During the development of AD, Aβ plaques form in the brain of patients as a result of accumulation of Aβ peptides resulting from the cleavage of amyloid precursor protein (APP) by γ-secretase and β-site APP cleaving enzyme 1 (Hampel et al., 2020). This evidence concerns the gene APP and Alzheimer disease.